Fudan University

Running trials

• Recruiting

  The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors

  NCT07159048· Source

• Not yet recruiting

  Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

  NCT07179939· Phase 2· Source

• Recruiting

  A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma

  NCT07105592· Phase 1/2· Source

• Recruiting

  Precision Palliative Care for Patients With Advanced Esophageal Cancer

  NCT06787313· Source

• Recruiting

  Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer

  NCT06841159· Phase 2· Source

• Recruiting

  China HEalthy Aging and Dementia Study (HEAD)

  NCT07912710· Source

• Recruiting

  A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

  NCT05150691· Phase 1/2· Source

• Recruiting

  Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

  NCT05024214· Phase 1/2· Source

• Recruiting

  Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

  NCT03983226· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer3 recruiting
• Colorectal cancer2 recruiting
• Gastric and esophageal cancer2 recruiting
• Lung cancer2 recruiting
• Alzheimer disease1 recruiting
• Endometrial cancer1 recruiting
• Head and neck cancer1 recruiting
• Kidney cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients

  NCT05673577· Phase 2· Source